(Q35213448)

7 August 2017

1 reference

title

Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma (English)

1 reference

Katherine A Lyseng-Williamson

7 August 2017

0 references

object named as

Katherine A Lyseng-Williamson

series ordinal

1

0 references

Greg L Plosker

series ordinal

2

object named as

Greg L Plosker

1 reference

PubMed ID

12959627

7 August 2017

language of work or name

1 reference

1 January 2003

1 reference

7 August 2017

1 reference

7 August 2017

21

1 reference

7 August 2017

13

1 reference

7 August 2017

951-989

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-200321130-00004

7 August 2017

0 references

cites work

Improving patient compliance with asthma therapy

1 reference

12 December 2020

Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone

1 reference

12 December 2020

Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo

1 reference

12 December 2020

Persistent asthma: disease control, resource utilisation and direct costs

1 reference

12 December 2020

The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines.

1 reference

12 December 2020

Low-dose inhaled corticosteroids and the prevention of death from asthma

1 reference

12 December 2020

Using health outcomes data to inform decision-making: patient perspective

1 reference

12 December 2020

Prospective study of the patient-level cost of asthma care in children.

1 reference

12 December 2020

Cost effectiveness of asthma management strategies

1 reference

12 December 2020

British guideline on the management of asthma

1 reference

12 December 2020

Categorizing asthma severity

1 reference

12 December 2020

1 reference

12 December 2020

Combination therapy with inhaled long-acting beta2-agonists and inhaled corticosteroids: a paradigm shift in asthma management

1 reference

12 December 2020

Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma

1 reference

12 December 2020

Epidemiology of asthma: the year in review

1 reference

12 December 2020

Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study

1 reference

12 December 2020

Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma

1 reference

12 December 2020

Patient factors and compliance with asthma therapy

1 reference

12 December 2020

1 reference

12 December 2020

Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population

1 reference

12 December 2020

Using economic evaluations to reduce the burden of asthma and chronic obstructive pulmonary disease

1 reference

12 December 2020

Achieving guideline-based asthma control: does the patient benefit?

1 reference

12 December 2020

Cost-effectiveness of adding an electron-beam boost to tangential radiation therapy in patients with negative margins after conservative surgery for early-stage breast cancer

1 reference

12 December 2020

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

12 December 2020

Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma

1 reference

12 December 2020

Using humanistic health outcomes data in asthma

1 reference

12 December 2020

Costs of asthma are correlated with severity: a 1-yr prospective study.

1 reference

12 December 2020

Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells

1 reference

12 December 2020

Budget impact model for determining the costs of introducing inhaled salmeterol/fluticasone propionate combination for the management of persistent asthma in France.

1 reference

12 December 2020

Patient perception of the diskus inhaler: a comparison with the turbuhaler inhaler

1 reference

12 December 2020

Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease.

1 reference

12 December 2020

Respiratory medications and risk of asthma death

1 reference

12 December 2020

Changing prevalence of allergic rhinitis and asthma

1 reference

12 December 2020

Impact of inhaled salmeterol/fluticasone propionate combination product versus budesonide on the health-related quality of life of patients with asthma

1 reference

12 December 2020

Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs

1 reference

12 December 2020

A 15-Year Follow-up Study of Ventilatory Function in Adults with Asthma

1 reference

12 December 2020

Inhaled salmeterol/fluticasone propionate combination. A pharmacoeconomic review of its use in the management of asthma

1 reference

12 December 2020

A study on the clinical equivalence and patient preference of fluticasone propionate 250 microg twice daily via the Diskus/Accuhaler inhaler or the Diskhaler inhaler in adult asthmatic patients

1 reference

12 December 2020

Compliance with US asthma management guidelines and specialty care: a regional variation or national concern?

1 reference

12 December 2020

Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma

1 reference

12 December 2020

The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma

1 reference

12 December 2020

Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma

1 reference

12 December 2020

Cost-effectiveness of angiography performed during surgery for ruptured intracranial aneurysms.

1 reference

12 December 2020

Reasons for and costs of hospitalization for pediatric asthma: a prospective 1-year follow-up in a population-based setting

1 reference

12 December 2020

Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee

1 reference

12 December 2020

Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids

1 reference

12 December 2020

Prevalence of asthma in adults in Busselton, Western Australia

1 reference

12 December 2020

Patient weighting of importance of asthma symptoms

1 reference

12 December 2020

Interactions between corticosteroids and beta-adrenergic agonists in asthma disease induction, progression, and exacerbation

1 reference

12 December 2020

Glucocorticoids induce beta2-adrenergic receptor function in human nasal mucosa

1 reference

12 December 2020

Variation in bronchial responsiveness in the European Community Respiratory Health Survey (ECRHS).

1 reference

12 December 2020

Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS)

1 reference

12 December 2020

Salmeterol/fluticasone propionate combination therapy 50/250 microg twice daily is more effective than budesonide 800 microg twice daily in treating moderate to severe asthma

1 reference

12 December 2020

Noncompliance with asthma therapy--are there solutions?

1 reference

12 December 2020

Asthma: from childhood to adulthood

1 reference

12 December 2020

Assessment of the Relationship Between Measures of Disease Severity, Quality of Life, and Willingness to Pay in Asthma

1 reference

12 December 2020

Forecasted state-specific estimates of self-reported asthma prevalence--United States, 1998

1 reference

12 December 2020

Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group

1 reference

12 December 2020

The natural history of asthma in adults: the problem of irreversibility

1 reference

12 December 2020

Salmeterol/Fluticasone combination inhaler: a new, effective and well tolerated treatment for asthma

1 reference

12 December 2020

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials

1 reference

12 December 2020

Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone

1 reference

12 December 2020

Measuring quality of life in asthma

1 reference

12 December 2020

Two-year retrospective economic evaluation of three dual-controller therapies used in the treatment of asthma

1 reference

12 December 2020

Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group

1 reference

12 December 2020

Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of Seretide (50/250 microg bd Diskus vs. formoterol (12 microg bd) and budesonide (800 microg bd) given concurrently (both via Turbuhaler) in patien

1 reference

12 December 2020

Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma

1 reference

12 December 2020

Cost-effectiveness of salmeterol/fluticasone propionate combination product 50/250 microg twice daily and budesonide 800 microg twice daily in the treatment of adults and adolescents with asthma. International Study Group

1 reference

12 December 2020

Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast

1 reference

12 December 2020

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Noncompliance and treatment failure in children with asthma

1 reference

12 December 2020

Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers

1 reference

12 December 2020

Development of an economic model to assess the cost effectiveness of asthma management strategies

1 reference

12 December 2020

Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma

1 reference

12 December 2020

[Epidemiology and costs of bronchial asthma and chronic bronchitis in Germany]

1 reference

12 December 2020

Comparison of prevalence, cost, and outcomes of a combination of salmeterol and fluticasone therapy to common asthma treatments

1 reference

12 December 2020

Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone

1 reference

12 December 2020

Health care utilization and cost in children with asthma and selected comorbidities.

1 reference

12 December 2020

Direct and indirect costs of asthma to an employer.

1 reference

12 December 2020

Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers

1 reference

12 December 2020

Impact of a multidisciplinary day program on disease and healthcare costs in children and adolescents with severe asthma: a two-year follow-up study.

1 reference

12 December 2020

Effect of salmeterol on patients' adherence to their prescribed refills for inhaled corticosteroids

1 reference

12 December 2020

10.2165/00019053-200321130-00004

Identifiers

DOI

1 reference

PubMed ID

12959627

Dimensions Publication ID

7 August 2017

0 references

1 reference

PubMed ID

12959627